Supplementation with aspalathin and sulforaphane protects cultured cardiac cells against dyslipidemia-associated oxidative damage

Sinenhlanhla X. H. Mthembu(South African Medical Research Council), Phiwayinkosi V. Dludla(University of Zululand)
Metabolism Open
January 5, 2025
10.1016/j.metop.2025.100346
Cited by 2

Related Papers

Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets
|Antioxidants|2021|33
Aspalathin Alleviates Skeletal Muscle Insulin Resistance and Mitochondrial Dysfunction
|Physiological Research|2022|5